Germany - The purpose of this notice is to conclude agreements with pharma
For more information and to make a bid you will need to go to the third party website.
Details
Provided by- Opportunity closing date
- 05 April 2025
- Opportunity publication date
- 06 August 2024
- Value of contract
- to be confirmed
- Your guide to exporting
Description
The purpose of this announcement is to conclude agreements with pharmaceutical companies within the meaning of Section 130a (8) sentence 1 SGB V. The invitation to participate is only addressed to pharmaceutical companies or employee associations of pharmaceutical companies within the meaning of Section 4 (18) of the German Medicines Act. It is not an open procedure pursuant to Section 15 VgV in conjunction with Section 119 (3) GWB, but rather a publication of the invitation to conclude\/join\/ rebate agreements with fixed and non-negotiable conditions for all participants, including the amount of the rebate. An unlimited number of pharmaceutical companies or employee associations of pharmaceutical companies within the meaning of Section 4 (18) of the German Medicines Act can become contracting parties.
- Opportunity closing date
- 05 April 2025
- Value of contract
- to be confirmed
About the buyer
- Address
- Deutsche Rentenversicherung Knappschaft-Bahn-See
Bid for tender
If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.
This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.
Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.
This opportunity has been translated from its original language. You should check if you need to apply in the original language.